{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:44:34Z","timestamp":1754160274846,"version":"3.41.2"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,26]]},"DOI":"10.7759\/cureus.88790","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T07:47:22Z","timestamp":1753516042000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic AA Amyloidosis Secondary to Chronic Bronchiectasis and Primary Immunodeficiency: A Case Report"],"prefix":"10.7759","author":[{"given":"Juhi","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Junaid","family":"Akram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Langman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini G","year":"2020","unstructured":"Palladini G, Milani P, Merlini G. Management of AL amyloidosis in 2020. Blood. 2020, 136:2620-7. 10.1182\/blood.2020006913","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.023","article-title":"AA amyloidosis secondary to primary immune deficiency: about 40 cases including 2 new French cases and a systematic literature review","volume":"9","author":"Delplanque M","year":"2021","unstructured":"Delplanque M, Galicier L, Oziol E, et al.. AA amyloidosis secondary to primary immune deficiency: about 40 cases including 2 new French cases and a systematic literature review. J Allergy Clin Immunol Pract. 2021, 9:745-52. 10.1016\/j.jaip.2020.09.023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill AT","year":"2019","unstructured":"Hill AT, Sullivan AL, Chalmers JD, et al.. British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019, 74:1-69. 10.1136\/thoraxjnl-2018-212463","journal-title":"Thorax"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla FA","year":"2015","unstructured":"Bonilla FA, Khan DA, Ballas ZK, et al.. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015, 136:1186-205. 10.1016\/j.jaci.2015.04.049","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini G","year":"2014","unstructured":"Palladini G, Hegenbart U, Milani P, et al.. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis. Blood. 2014, 124:2325-32. 10.1182\/blood-2014-04-570010","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson MM","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, et al.. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020, 142:e7-22. 10.1161\/CIR.0000000000000792","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.087619","article-title":"Update on treatment of light chain amyloidosis","volume":"99","author":"Mahmood S","year":"2014","unstructured":"Mahmood S, Palladini G, Sanchorawala V, Wechalekar A. Update on treatment of light chain amyloidosis. Haematologica. 2014, 99:209-21. 10.3324\/haematol.2013.087619","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri A","year":"2004","unstructured":"Dispenzieri A, Gertz MA, Kyle RA, et al.. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004, 22:3751-7. 10.1200\/JCO.2004.03.029","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384313-systemic-aa-amyloidosis-secondary-to-chronic-bronchiectasis-and-primary-immunodeficiency-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T07:47:23Z","timestamp":1753516043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384313-systemic-aa-amyloidosis-secondary-to-chronic-bronchiectasis-and-primary-immunodeficiency-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.88790","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,26]]}}}